| Application no. and date | 14715578.2 (espacenet) (Federated) (European Patent Register), 20140403 | | Patent/reg. no. and date | DK/EP 2981271, 20181114 | | Publication date | 20160210 | | Priority no. and date | US 201361808804 P, 20130405, CA 2812519, 20130410, US 201361908991 P, 20131126 | | EP pub. no. and date |
EP 2981271 20160210 | | Effective date | | | Applicant/owner | Boehringer Ingelheim International GmbH, Binger Strasse 173
55216 Ingelheim am Rhein, DE | | Applicant ref. no. | 162081 | | Inventor | WOERLE, Hans-Juergen, Boehringer Ingelheim GmbH
Corporate Patents
Binger Strasse 173
55216 Ingelheim Am Rhein, DE,
BROEDL, Uli, Boehringer Ingelheim GmbH
Corporate Patents
Binger Strasse 173
55216 Ingelheim Am Rhein, DE,
VON EYNATTEN, Maximilian, Boehringer Ingelheim GmbH
Corporate Patents
Binger Strasse 173
55216 Ingelheim Am Rhein, DE,
MACHA,Sreeraj, Boehringer Ingelheim USA Corp.
c/o VP
IP
Legal
900 Ridgebury Road
P.O. Box 368
Ridgefield, Connecticut 06877-0368, US | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/7048 (2006.01) , A61P 13/12 (2006.01) , A61P 3/10 (2006.01) | | Title | Terapeutiske anvendelser af empagliflozin | | Int. application no. | EP2014056657 | | Int. publication no. | WO2014161919 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
